Infinity Pharmaceuticals (INFI) Earnings
|
Expand Research on INFI
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -1.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +12.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/1/23 | Q323 | N/A | -$0.12 | N/A | N/A | $700K | N/A | N/A | N/A | ||
| 8/8/23 | Q223 | N/A | -$0.12 | N/A | N/A | $700K | N/A | N/A | N/A | ||
| 8/14/23 | Q223 | N/A | -$0.12 | N/A | N/A | $700K | N/A | N/A | N/A | ||
| 8/21/23 | Q223 | N/A | -$0.12 | N/A | N/A | $700K | N/A | N/A | N/A | ||
| 8/28/23 | Q223 | N/A | -$0.12 | N/A | N/A | $700K | N/A | N/A | N/A | ||
| 5/9/23 | Q123 | N/A | -$0.11 | N/A | N/A | $600K | N/A | N/A | N/A | ||
| 5/29/23 | Q123 | N/A | -$0.11 | N/A | N/A | $600K | N/A | N/A | N/A | ||
| 5/22/23 | Q123 | N/A | -$0.11 | N/A | N/A | $600K | N/A | N/A | N/A |
